Braun Beteiligungs GmbH Report issue

Contributed to NME For profit Phase 4
Founded: Greifswald Germany (1973)
Status: Defunct (1981)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1973
amino acids (Freamine)
First NDA Approval
None
Last Known Activity
1971

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Marketed Drugs (3)

amino acids (Freamine) (1971 NDA)

phosphoric acid (Freamine) (NDA)

valganciclovir (Valcyte) (2009)

Drugs in Phase 4 Trials (1)

Key: Braun Beteiligungs GmbH (0) Acquired (1)

yohimbine (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1